| 11 April 2013
Pharmaceutical manufacturing giant Pfizer has announced that its breast cancer candidate palbociclib has received a new and coveted breakthrough product designation from the US Food and Drug Read More...
| 8 April 2013
The US Food and Drug Administration (FDA) has granted its third breakthrough product designation and the first for an entirely unapproved product, the product's sponsor, Jenssen, announced Read More...
| 23 April 2012
Former US Food and Drug Administration (FDA) Commissioner Mark McClellan, now a member of the think tank The Brookings Institute, penned an opinion piece in The Hill in which he argues FDA must take Read More...